7:30 a.m. | Registration and Continental Breakfast |
8:00 a.m. | Opening Remarks |
SOLID ORGAN TRANSPLANT |
8:15 a.m. | Multidisciplinary Management of End-Stage Renal Disease and Kidney and Pancreas Transplantation, Dixon B. Kaufman, MD, PhD, FACS, University of Wisconsin Hospital and Clinics
Diabetes is one of the leading causes of end-stage renal disease (ESRD) and the most frequent indication for kidney transplantation. Kidney and pancreas transplantation is an established definitive treatment for selected type 1 diabetic patients with end-stage diabetic nephropathy. A multidisciplinary team approach is paramount in the success of the transplant. This session will discuss the importance of a multidisciplinary team, patient selection, and the management of kidney and pancreas transplant patients pre- and post-transplant. Efforts to increase the number of available donor kidneys by facilitating additional donations of living donor kidneys will also be discussed.
Learning Objectives: - Discuss patient selection, evaluation, posttransplant management, and complications of kidney and pancreas transplant.
- Describe the importance of a multidisciplinary approach for successful outcomes.
- Explain the significance of kidney paired donation and preemptive transplant in facilitating outcomes for kidney transplantation.
|
9:15 a.m. | Thoracic Transplantation: Heart and Lung, Greg Richardson, RN, CCTC, Barnes-Jewish Hospital
For many patients with end-stage heart failure who remain symptomatic despite optimal medical therapy, heart transplantation is the treatment of choice. Over the past decade, lung transplantation has become an increasingly important mode of therapy for patients with a variety of end-stage lung diseases. The ultimate decision to place a patient on the heart or lung transplant waiting list is made by clinicians at the transplant center based upon a combination of test data and clinical judgment. Candidates for heart and lung transplantation are generally younger persons with a fatal disease, and the transplant process offers hope. This session will discuss the advantages of a comprehensive multidisciplinary approach to managing thoracic transplant recipients. Indications and contraindications for transplant and how a team can work together to achieve optimal patient outcomes will be presented.
Learning Objectives: - Outline the process of patient selection, evaluation, and long-term posttransplant management for heart and lung transplant patients.
- List the indications and contraindications for thoracic transplant.
- Discuss the importance of a multidisciplinary team approach to maximize patient outcomes.
|
10:15 a.m. | Break |
10:30 a.m. | Intestinal Rehabilitation and Transplantation, Cal S. Matsumoto, MD, MedStar Georgetown Transplant Institute
An intestinal transplant is a last-resort treatment option for patients with intestinal failure who develop life-threatening complications from total parenteral nutrition. Over the last 15 years, intestinal transplant outcomes have significantly improved and the number of transplants performed annually has steadily increased. Recent advances in small bowel transplantation and nontransplant surgical techniques now offer hope of sustained survival in the future without parenteral nutrition. This session will discuss the advantages of a comprehensive multidisciplinary approach to treating intestinal failure, indications for transplant, and how a team can work together to achieve optimal patient outcomes.
Learning Objectives: - Define intestinal failure and identify potential causes.
- Discuss the long-term complications associated with intestinal failure.
- Recognize the indications for intestinal transplant.
- Describe the benefits of an intestinal-failure-program approach that combines the expertise of both rehabilitation and transplantation.
|
11:15 a.m. | Pharmaceuticals in Organ Transplantation, Rebecca L. Corey, PharmD, BCPS, and Jenise Stephen, PharmD, Mayo Clinic Arizona
Immunosuppression management post transplantation has evolved substantially. With ongoing clinical trials, acute rejection is typically easy to manage, and the current challenge is balancing the risk of rejection with the risk of drug toxicity. This session will address effective use of the most updated protocols for immunosuppression in solid organ transplantation.
Learning Objectives: - Explain the mechanism of action of immunosuppressive agents along with the major adverse effects for each agent.
- Review the different classes of immunosuppressive medications used in transplantation.
- Discuss how immunosuppressive regimens may vary and identify best practices.
- State the importance of establishing an individualized immunosuppression regimen posttransplant.
|
12:00 p.m. | Luncheon Presentation: Ethics in Transplant, Giuliano Testa, MD, FACS, MBA, Baylor University Medical Center
A primary ethical dilemma surrounding organ transplantation arises from the shortage of available organs. Because of this shortage, patients may look for a living donor to donate an organ, allowing them to bypass the national waiting pool to receive a cadaveric organ. This session will discuss the ethical principle of coercion as it relates to living organ donor transplantation and will also address other ethical issues in solid organ transplantation.
Learning Objectives: - Recognize and discuss the ethical principle of coercion as it relates to living organ donor transplantation.
- Identify and discuss two ethical issues related to solid organ transplantation.
|
1:00 p.m. | Dessert Break |
1:15 p.m. | Posttransplant Complications in Solid Organ Transplants, Anil Seetharam, MD, Banner Health Good Samaritan Medical Center
After a patient receives a transplanted organ, several complications may occur including infection, malignancy, bone disease, and cardiovascular disease. This session will discuss the management of short- and long-term posttransplant complications. Learning Objectives: - Identify potential short- and long-term complications posttransplant including infection, malignancy, bone disease, and cardiovascular disease.
- Explain the medical and pharmacologic management of posttransplant complications.
|
2:00 p.m. | Heart Failure and Ventricular Assist Devices, Suzanne Chilcott, BSN, RN, Sharp Memorial Hospital
While the demand for heart transplantation has increased, the limited availability of hearts has remained constant. To bridge this gap, ventricular assist devices (VADs) are being used to enable patients to survive until a heart becomes available, or in some cases, to extend the lives of patients who do not qualify for a heart transplant. Managing patients on chronic VAD support requires regular patient follow-up and multidisciplinary care teams. This presentation will review management strategies to reduce morbidity and mortality in heart failure patients supported chronically with VADs and describe candidate selection, outpatient strategies to optimize device performance, complications that warrant close monitoring, heart failure management, and currently available devices.
Learning Objectives: - Review management strategies to reduce morbidity and mortality in heart failure patients supported chronically with VADs.
- Describe candidate selection, outpatient strategies to optimize device performance, and complications that warrant close monitoring.
- Provide an overview of the VADs currently available.
|
2:45 p.m. | Liver Transplant: Patient Selection, Indications, and Optimizing Outcomes, R. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed), Methodist J.C. Walter Jr. Transplant Center
Liver transplantation is a treatment option for patients with acute liver failure, end-stage liver disease, and primary hepatic malignancy. Specialists from a variety of fields are needed to assess if a liver transplant is appropriate and often a team of such specialists are assembled to evaluate and determine candidates for a liver transplant. The decision to list a patient for transplantation is based on a number of factors including the inherent risks of surgery, recurrent disease, and long-term immunosuppression—all of which are weighed against the potential benefits of transplantation. This session will discuss diseases that are treated with liver transplantation, the process of patient selection, evaluation, and surgical techniques used in liver transplant, along with the importance of a multidisciplinary team for optimal outcomes.
Learning Objectives: - Outline the process of patient selection, evaluation, and surgical techniques used in liver transplantation.
- List diseases that are treatable with liver transplantation.
- Discuss the importance of a multidisciplinary team approach for optimal transplant outcomes.
|
3:30 p.m. | Adjourn |